Skip to main content
. 2015 Jun 26;10(6):e0130373. doi: 10.1371/journal.pone.0130373

Table 3. Polymorphisms in plasma treated P. aeruginosa variants.

Gene Product Variant Change Position Polymorphism type
Probable pyridoxamine 5-phosphate oxidase followed by phenazine biosynthesis protein 5P2 C -> T 6,349,784 SNP (transition)
Phenazine biosynthesis protein PhzE 2P1, 2P2 A -> G 6,351,727 SNP (transition)
Phenazine biosynthesis protein PhzD 2P2, 5P1, 5P2 T -> C 6,353,019 SNP (transition)
2P1, 2P2, 5P1, 5P2 T -> C 6,353,125 SNP (transition)
Putative transcriptional regulator (AAA domain protein) 2P1, 2P2 C -> T 1,197,847 SNP (transition)
Diaminopimelate decarboxylase 2P2 T -> A 2,157,427 SNP (transversion)
Conjugal transfer protein 2P1 G -> C 2,945,334 SNP (transversion)
2P1, 2P2 G -> A 2,945,346 SNP (transition)
2P1, 2P2 GT -> AC 2,945,350 Substitution
Intergenic region between 16S RNA gene and putative membrane protein 5P1 T -> G 5,174,776 SNP (transversion)

(2P1, 2P2 = recovered after 2 min plasma treatment; 5P1, 5P2 = recovered after 5 min plasma treatment)